Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus (Q35583882)

9 August 2017

1 reference

title

Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus (English)

1 reference

9 August 2017

0 references

1 reference

1 reference

10.1023/A:1027397911746

https://api.crossref.org/works/10.1023/A:1027397911746

2 April 2024

author name string

Geremia B. Bolli

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14618018

2 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14618018

2 April 2024

publication date

1 December 2003

1 reference

Reviews in Endocrine and Metabolic Disorders

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

335-341

1 reference

Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus

9 August 2017

cites work

1 reference

12 December 2020

Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus

1 reference

12 December 2020

Reversibility of unawareness of hypoglycemia in patients with insulinomas

1 reference

12 December 2020

Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans

1 reference

12 December 2020

Avoidance of hypoglycemia restores hypoglycemia awareness by increasing beta-adrenergic sensitivity in type 1 diabetes

1 reference

12 December 2020

Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans

1 reference

12 December 2020

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

12 December 2020

Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction

1 reference

12 December 2020

Hypoglycemia Unawareness

1 reference

12 December 2020

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime

1 reference

12 December 2020

Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects

1 reference

12 December 2020

Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release

1 reference

12 December 2020

Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes.

1 reference

12 December 2020

Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM

1 reference

12 December 2020

Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.

1 reference

12 December 2020

Adaptation in brain glucose uptake following recurrent hypoglycemia

1 reference

12 December 2020

Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia

1 reference

12 December 2020

Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia

1 reference

12 December 2020

Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes Mellitus

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

1 reference

12 December 2020

Chronic hypoglycemia increases brain glucose transport

1 reference

12 December 2020

Ketone infusion lowers hormonal responses to hypoglycaemia: Evidence for acute cerebral utilization of a non-glucose fuel

1 reference

12 December 2020

Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans.

1 reference

12 December 2020

Hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1027397911746

1 reference

Dimensions Publication ID

9 August 2017

1010120017

0 references

1 reference